Resultats de la cerca - Dominique Descamps

Refinar resultats
  1. 1
    Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials

    Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials per Dominique Descamps, Karin Hardt, Bart Spiessens, Patricia Izurieta, Thomas Verstraeten, Thomas Breuer, Gary Dubin

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

    Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach per Nathalie Garçon, Sandra Morel, Arnaud M. Didierlaurent, Dominique Descamps, Martine Wettendorff, Marcelle Van Mechelen

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women

    Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women per Tiina Petäjä, Court Pedersen, Airi Põder, Gitte Strauss, Grégory Catteau, Florence Thomas, Matti Lehtinen, Dominique Descamps

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆

    Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆ per Marie‐Pierre David, Koen Van Herck, Karin Hardt, Fabián Tibaldi, Gary Dubin, Dominique Descamps, Pierre Van Damme

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study

    Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study per Lynette Denny, Bronwyn Hendricks, Chivaugn Gordon, Florence Thomas, Marjan Hezareh, Kurt Dobbelaere, Christelle Durand, Caroline Hervé, Dominique Descamps

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial

    Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With... per Reynaldo Chandler, Nathali Montenegro, Cecilia Llorach, Lorena Noriega, Sophie Germain, Sherine Kuriyakose, Axel Lambert, Dominique Descamps, Aurélie Olivier, Veronica Hulstrøm

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine

    Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine per Cecília Roteli-Martins, Paulo Naud, P. De Borba, Júlio César Teixeira, Newton Sérgio de Carvalho, Toufik Zahaf, Nervo Sánchez, Brecht Geeraerts, Dominique Descamps

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years

    Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years per Tino F. Schwarz, Li‐Min Huang, Doris Maribel Rivera Medina, Alejandra Valencia, Tzou‐Yien Lin, Ulrich Behre, Grégory Catteau, Florence Thomas, Dominique Descamps

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

    Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule per Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Grégory Catteau, Kurt Dobbelaere, Anne Schuind, Dominique Descamps

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

    Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine per Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho, Júlio César Teixeira, Paola Colares de Borba, Nervo Sánchez, Toufik Zahaf, Grégory Catteau, Brecht Geeraerts, Dominique Descamps

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine

    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine per Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, Bradley Fox, Sofia Scholar, Jeffrey B. Rosen, Nahida Chakhtoura, Dorothée Meric, Francis Dessy, Sanjoy Datta, Dominique Descamps, Gary Dubin

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years

    Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women a... per Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, Bradley Fox, Sofia Scholar, Jeffrey B. Rosen, Nahida Chakhtoura, Marie Lebacq, Robbert van der Most, Philippe Moris, Sandra L. Giannini, Anne Schuind, Sanjoy Datta, Dominique Descamps

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women

    Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women per Papa Salif Sow, Deborah Watson‐Jones, Nancy B. Kiviat, John Changalucha, Khardiata Diallo Mbaye, Joelle Brown, Kouro Bousso, Bazil Baltazar Kavishe, Aura Andreasen, Macoumba Touré, Saidi Kapiga, Philippe Mayaud, Richard Hayes, Marie Lebacq, Marjan Herazeh, Florence Thomas, Dominique Descamps

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Efficacy, immunogenicity and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial

    Efficacy, immunogenicity and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial per Fengcai Zhu, Wen Chen, Yuemei Hu, Ying Hong, Juan Li, Xun Zhang, Yiju Zhang, Qin‐Jing Pan, Fanghui Zhao, Jia‐Xi Yu, Yanshu Zhang, Xiaoping Yang, Chengfu Zhang, Haïwen Tang, Baiyu Zhang, Marie Lebacq, Marie‐Pierre David, Sanjoy Datta, Frank Struyf, Dan Bi, Dominique Descamps

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years

    Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years... per Thanyawee Puthanakit, Li‐Min Huang, Cheng‐Hsun Chiu, Ren-Bin Tang, Tino F. Schwarz, Susanna Esposito, Louise Frenette, Carlo Giaquinto, Shelly McNeil, Paul Rheault, Paolo Durando, Michael Horn, Maximilian Klar, Sylviane Poncelet, Stéphanie De Simoni, Damien Friel, Benoit De Muynck, P.V. Suryakiran, Marjan Hezareh, Dominique Descamps, Florence Thomas, Frank Struyf

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial

    Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial per Édith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Henry C Kitchener, Xavier Castellsagué, Júlio César Teixeira, S. Rachel Skinner, Unnop Jaisamrarn, Genara Limson, Suzanne M. Garland, Anne Szarewski, Barbara Romanowski, Fred Y. Aoki, Tino F. Schwarz, Willy Poppe, Newton Sérgio de Carvalho, Diane M. Harper, F. Xavier Bosch, Alice Raillard, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary Dubin

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

    Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomize... per Dan Apter, Cosette M. Wheeler, Jorma Paavonen, Xavier Castellsagué, Suzanne M. Garland, S. Rachel Skinner, Paulo Naud, Jorge Salmerón, Song‐Nan Chow, Henry C Kitchener, Júlio César Teixeira, Unnop Jaisamrarn, Genara Limson, Anne Szarewski, Barbara Romanowski, Fred Y. Aoki, Tino F. Schwarz, Willy Poppe, F. Xavier Bosch, Adrian Mindel, P. De Sutter, Karin Hardt, Toufik Zahaf, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary Dubin

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: <i>Post‐hoc</i> analysis from a randomized controlled trial

    Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: <i>Post‐hoc</i> ana... per Suzanne M. Garland, Jorma Paavonen, Unnop Jaisamrarn, Paulo Naud, Jorge Salmerón, Song‐Nan Chow, Dan Apter, Xavier Castellsagué, Júlio César Teixeira, S. Rachel Skinner, James Hedrick, Genara Limson, Tino F. Schwarz, Willy Poppe, F. Xavier Bosch, Newton Sérgio de Carvalho, Maria Julieta V. Germar, Klaus Peters, Maria Rowena Del Rosario‐Raymundo, Grégory Catteau, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary Dubin

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

    Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18 per Anne Szarewski, W.A.J. Poppe, S. Rachel Skinner, Cosette M. Wheeler, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song‐Nan Chow, Dan Apter, Henry C Kitchener, Xavier Castellsagué, Júlio César Teixeira, James Hedrick, Unnop Jaisamrarn, Genara Limson, Suzanne M. Garland, Barbara Romanowski, F. Y. Aoki, Tino F. Schwarz, F. Xavier Bosch, Diane M. Harper, Karin Hardt, Toufik Zahaf, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary Dubin

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

    Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized... per Nicolas Folschweiller, Júlio César Teixeira, Smita Joshi, Luciano Z. Goldani, Khuanchai Supparatpinyo, Partha Basu, Tawee Chotpitayasunondh, Ploenchan Chetchotisakd, Kiat Ruxrungtham, Cecília Roteli-Martins, Beatriz Grinsztejn, Silvana Maria Quintana, Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, Vinay Kulkarni, Lan Lin, Sanjoy Datta, Dominique Descamps, Monique Dodet, Gary Dubin, Damien Friel, Marjan Hezareh, Naveen Karkada, Dorothée Camilleri, Sylviane Poncelet, Bruno Salaun, Fernanda Tavares Da Silva, Florence Thomas-Jooris, Frank Struyf

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: